Harvey Capital Management Inc Aquestive Therapeutics, Inc. Transaction History
Harvey Capital Management Inc
- $422 Million
- Q4 2024
A detailed history of Harvey Capital Management Inc transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Harvey Capital Management Inc holds 267,390 shares of AQST stock, worth $748,692. This represents 0.22% of its overall portfolio holdings.
Number of Shares
267,390
Previous 17,600
1419.26%
Holding current value
$748,692
Previous $87,000
987.36%
% of portfolio
0.22%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
121Shares Held
43.3MCall Options Held
504KPut Options Held
148K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$27.5 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$15.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$12.2 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.63MShares$7.36 Million1.54% of portfolio
-
Franklin Resources Inc San Mateo, CA2.13MShares$5.98 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $149M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...